Key result
SARS-CoV-2 infection can lead to the rapid development of subacute effusive-constrictive pericarditis, representing a rare but severe cardiac complication.
Highlights a rare but severe cardiac complication of COVID-19, specifically the rapid development of subacute effusive-constrictive pericarditis.
Alerts clinicians to monitor for pericarditis in COVID-19; leaves open incidence and management.
We report the case of a previously healthy young woman, who developed a severe form of COVID-19 with massive pneumonia and acute pericarditis in whom constrictive physiology developed rapidly. To our knowledge, this represents the second reported case of SARS-CoV-2 constrictive pericarditis, a rare, but severe cardiac complication.
No takes yet. Share an insight, caveat, or question.
Diaconu et al. (2021) studied this question. SARS-CoV-2 infection can lead to the rapid development of subacute effusive-constrictive pericarditis, representing a rare but severe cardiac complication.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: